Cargando…
Womens heart and estrogens.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
[Place of publication not identified] :
Bentham Science Publisher
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- FOREWORD ; PREFACE ; Estrogens and Atherogenesis ; 1. INTRODUCTION; 2. ATHEROGENESIS; Cholesterol and Atherogenesis; 3. STAGES OF ATHEROGENESIS; 3.1. Initiation and Plaque Formation; Intimal Thickening, Fatty Streak Formation; Plaque Formation; Complicated Plaque; 3.2. Adaptation Stage; 3.3. Clinical Manifestation; 4. ESTROGENS AND STAGES OF ATHEROGENESIS; 5. ATHEROGENESIS
- PROMOTING FACTORS; 6. GENES INVOLVED IN ATHEROGENESIS IN YOUNG WOMEN; 6.1. Familial Hypercholesterolemia; 6.2. Sitosterolemia; 6.3. Apolipoprotein E Gene Polymorphisms.
- 6.4. Cholesteryl Ester Transfer Protein Gene Polymorphisms6.5. Estrogen Receptor Gene Polymorphisms; DISCLOSURE; MAIN POINTS OF CHAPTER 1; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Cardiovascular Actions of Estrogens ; 1. INTRODUCTION; 2. ESTROGENS BIOSYNTHESIS; 3. ACTIONS OF ESTROGENS; 4. CARDIOVASCULAR ACTIONS OF ESTROGENS; 4.1. Vasodilation Effects of Estrogens; 4.2. Anti-Inflammatory Effects of Estrogens; 4.3. Anti-Proliferative Effects of Estrogens; 4.4. Effects of Estrogens on Vascular Endothelium; 4.5. Women with Normal Endogenous Estrogens Concentration and Coronary Heart Disease.
- 4.5.1. Vasculitis and Autoimmune Diseases4.5.2. Hypercoagulable States; 4.5.3. Non-Atherosclerotic Coronary Heart Disease; 4.5.4. Myocardial Infarction in Hallucinogenic Drug Abusers; 4.5.5. Atherosclerotic Coronary Heart Disease; 4.6. Pregnancy and Coronary Heart Disease; 5. ESTROGENS, LIPIDS AND LIPOPROTEINS CONCENTRATION; 5.1. Actions of Estrogens on Lipid Metabolism; 5.2. Fasting Lipids and Lipoproteins Concentration And Estrogens; 5.3. Nonfasting Triglycerides Concentration and Estrogens; 5.3.1. Postprandial Lipemia and Estrogens; 6. HEMATOLOGICAL FACTORS AND ESTROGENS.
- 7. BODY COMPOSITION AND ESTROGENS8. ARTERIAL BLOOD PRESSURE AND ESTROGENS; 9. PLASMA GLUCOSE CONCENTRATION AND ESTROGENS; MAIN POINTS OF CHAPTER 2; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Menopause ; 1. INTRODUCTION; 2. MENOPAUSE AND CARDIOVASCULAR SYSTEM; 3. AGEING, MENOPAUSE AND ALTERNATIONS OF LIPID METABOLISM; 3.1. Ageing; 3.2. Menopause; 3.3. Menopause and Postprandial Hypertriglyceridemia; 4. HEMATOLOGIACAL FACTORS AND MENOPAUSE; 5. BODY COMPOSITION IN MENOPAUSAL WOMEN; 6. MENOPAUSE-RELATED ALTERATIONS IN BLOOD PRESSURE; 7. PLASMA GLUCOSE LEVELS IN MENOPAUSAL WOMEN.
- MAIN POINTS OF CHAPTER 3CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Studies Evaluated Cardiovascular Events in Women Receiving Hormone Replacement Therapy ; 1. INTRODUCTION; 2. STUDIES EVALUATING CARDIOVASCULAR EVENTS IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY ; 2.1. Heart and Estrogen/Progestin Replacement Study (HERS), 1998 ; 2.1.1. HERS Study and Peripheral Arterial Disease, 2000; 2.1.2. HERS Study and Stroke, 2001; 2.1.3. HERS Study and Blood Glucose Levels, 2003; 2.1.4. HERS Study and Uric Acid Levels, 2006; 2.2. Estrogen Replacement and Atherosclerosis Trial (ERA), 2000.